NCT02164838 · Interventional trial
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Overall registry status Completed
Phase 1
Conditions Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
Delaware Valley sites
- Childrens Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory